EFTA00314057.pdf

89/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 6/13 Lahcorp Patient Report Patient EPSTEIN, JEFFREY DOB 0I O0'1953 Patient ID' r 33 r.43092 Specuraen ID: 2 S7-180-:371 -0 Con trot Date collecteck 09/14 2018 1255 oc TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Lipoprotein (a) 20 nmol/L <75 01 Note: Values greater than or equal to 75 nmol/L may indicate an independent risk factor for CUD, but must be evaluated with caution when applied to non-Caucasian populations due to the influence of genetic factors on Lp(a) across ethmicities. IGP-1 Insulin-Like Growth Factor I 137 ng/mL 49 - 188 02 ANA w/Reflex ANA Direct Negative Negative 01 Homocyst(e)ine, Plasma 14.9 umol/L 0.0 - 15.0 01 Prolactin 3.9 Low ng/mL 4.0 - 15.2 01 Thyroxine (T4) Free, Direct, S T4,Rree(Direct) 1.05 ng/dL 0.82 - 1.77 01 Cortisol 3.7 ug/dL 01 Cortisol AM. 6.2 - 19.4 Cortisol PM 2.3 - 11.9 oaaA-sulfate 181.8 ug/dL 30.9 - 295.6 01 Estradiol 28.3 pg/mL 7.6 - 42.6 01 Roche ECLIA methodology Uric Acid Uric Acid 6.8 mg/dL 3.7 - 8.6 01 Please Note: 01 Therapeutic target for gout patients: <6.0 Phosphorus 3.6 mg/dL 2.5 - 4.5 01 LDH 213 IU/L 121 - 224 01 GGT 25 IU/L 0 - 65 01 keyless 37 U/L 31 - 124 01 serritin, Serum 104 ng/mL 30 - 400 01 Insulin 47.2 High 2.6 - 24.9 uIU/mIJ 01 Dflehus109/2006M102ET FINAL REPORT PageSd6 This document comaint poen and coreelentiellweldi sionnatron protected by ream and federal ten el9954M6LationftwyCarpornisIOMmecOMAIngs rt you an manned this document In *non plow cm] negowsilennes-exeptinattersiet too EFTA00314057